Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Progyny stock in Canada | $61.93
Own Progyny shares in just a few minutes.
Progyny (PGNY) is a leading health information services business based in the US. It opened the day at $59.85 after a previous close of $59.55. During the day the price has varied from a low of $59.25 to a high of $61.96. The latest price was $61.93 (25 minute delay). Progyny is listed on the NASDAQ and employs 210 staff. All prices are listed in US Dollars.
How to buy Progyny stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: PGNY in this case.
- Research Progyny stocks. The platform should provide the latest information available.
- Buy your Progyny stocks. It's that simple.
What's in this guide?
- Can I buy shares in Progyny?
- Has coronavirus impacted Progyny shares?
- Progyny shares summary
- Compare share dealing platforms
- Is Progyny stock a buy or sell?
- Progyny performance over time
- Can I short Progyny shares?
- Are Progyny shares over-valued?
- Progyny's financials
- Does Progyny pay a dividend?
- Other common questions
How has Coronavirus impacted Progyny's stock price?
Since the stock market crash in March caused by coronavirus, Progyny's stock price has had significant positive movement.
Its last market close was $64.04, which is 53.17% up on its pre-crash value of $29.99 and 310.78% up on the lowest point reached during the March crash when the stocks fell as low as $15.59.
If you had bought $1,000 worth of Progyny stocks at the start of February 2020, those stocks would have been worth $617.95 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $2,402.78.
Progyny stock priceUse our graph to track the performance of PGNY stocks over time.
Progyny stocks at a glance
|52-week range||$23.56 - $66.61|
|50-day moving average||$60.685|
|200-day moving average||$52.1772|
|Wall St. target price||$66.33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.581|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Progyny stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Progyny price performance over time
|1 month (2021-06-25)||4.00%|
|3 months (2021-04-26)||10.79%|
Is Progyny under- or over-valued?
Valuing Progyny stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Progyny's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Progyny's P/E ratio
Progyny's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 97x. In other words, Progyny stocks trade at around 97x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stocks or simply that they're over-valued.
Progyny's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$27.9 million.
The EBITDA is a measure of a Progyny's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$386 million|
|Operating margin TTM||6.75%|
|Gross profit TTM||USD$70.1 million|
|Return on assets TTM||6.86%|
|Return on equity TTM||37.94%|
|Market capitalisation||USD$5 billion|
TTM: trailing 12 months
How to short and sell Progyny stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "PGNY.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 4.0 million Progyny stocks held short by investors – that's known as Progyny's "short interest". This figure is 47.9% up from 2.7 million last month.
There are a few different ways that this level of interest in shorting Progyny stocks can be evaluated.
Progyny's "short interest ratio" (SIR)
Progyny's "short interest ratio" (SIR) is the quantity of Progyny stocks currently shorted divided by the average quantity of Progyny stocks traded daily (recently around 1.3 million). Progyny's SIR currently stands at 3.02. In other words for every 100,000 Progyny stocks traded daily on the market, roughly 3020 stocks are currently held short.
However Progyny's short interest can also be evaluated against the total number of Progyny stocks, or, against the total number of tradable Progyny stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Progyny's short interest could be expressed as 0.05% of the outstanding stocks (for every 100,000 Progyny stocks in existence, roughly 50 stocks are currently held short) or 0.0596% of the tradable stocks (for every 100,000 tradable Progyny stocks, roughly 60 stocks are currently held short).
Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Progyny.
Find out more about how you can short Progyny stock.
Progyny stock dividends
We're not expecting Progyny to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Progyny in the news
ClearBridge Sustainability Leaders Strategy Portfolio Manager Commentary Q2 2021
Progyny, Inc. Announces Details for Its Second Quarter 2021 Results Report
Progyny (PGNY) Moves to Strong Buy: Rationale Behind the Upgrade
Frequently asked questions
More guides on Finder
How to buy Zevia PBC (ZVIA) stock in Canada
Everything we know about the Zevia PBC IPO, plus information on how to buy in.
How to buy Xponential Fitness (XPOF) stock in Canada
Everything we know about the Xponential Fitness IPO, plus information on how to buy in.
How to buy SOPHiA Genetics (SOPH) stock in Canada
Everything we know about the SOPHiA Genetics IPO, plus information on how to buy in.
How to buy Ryan Specialty Group Holdings (RYAN) stock in Canada
Everything we know about the Ryan Specialty Group Holdings IPO, plus information on how to buy in.
How to buy Ocean Biomedical (OCEA) stock in Canada when it goes public
Everything we know about the Ocean Biomedical IPO, plus information on how to buy in.
How to buy Instructure Holdings (INST) stock in Canada
Everything we know about the Instructure Holdings IPO, plus information on how to buy in.
How to buy Gambling.com Group (GAMB) stock in Canada
Everything we know about the Gambling.com Group IPO, plus information on how to buy in.
How to buy Elicio Therapeutics (ELTX) stock in Canada when it goes public
Everything we know about the Elicio Therapeutics IPO, plus information on how to buy in.
How to buy Cytek Biosciences (CTKB) stock in Canada
Everything we know about the Cytek Biosciences IPO, plus information on how to buy in.
How to buy Core & Main (CNM) stock in Canada
Everything we know about the Core & Main IPO, plus information on how to buy in.
Ask an Expert
You must be logged in to post a comment.